NO20013101L - Ytre overflateproteiner, deres gener og deres anvendelse - Google Patents

Ytre overflateproteiner, deres gener og deres anvendelse

Info

Publication number
NO20013101L
NO20013101L NO20013101A NO20013101A NO20013101L NO 20013101 L NO20013101 L NO 20013101L NO 20013101 A NO20013101 A NO 20013101A NO 20013101 A NO20013101 A NO 20013101A NO 20013101 L NO20013101 L NO 20013101L
Authority
NO
Norway
Prior art keywords
genes
surface proteins
streptococcus
immunization
vaccines
Prior art date
Application number
NO20013101A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013101D0 (no
Inventor
Martin John Glenton Hughes
Joseph David Santangelo
Jonathan Douglas Lane
Robert Feldman
Joanne Christine Moore
Richard James Dobson
Caroline Joanne Henwood
Paul Everest
Rebecca Kerry Wilson
Gordon Dougan
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828346.8A external-priority patent/GB9828346D0/en
Priority claimed from GBGB9901234.6A external-priority patent/GB9901234D0/en
Priority claimed from GBGB9901233.8A external-priority patent/GB9901233D0/en
Priority claimed from GBGB9908321.4A external-priority patent/GB9908321D0/en
Priority claimed from GBGB9912036.2A external-priority patent/GB9912036D0/en
Priority claimed from GBGB9922596.3A external-priority patent/GB9922596D0/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of NO20013101D0 publication Critical patent/NO20013101D0/no
Publication of NO20013101L publication Critical patent/NO20013101L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1003Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1018Carboxy- and carbamoyl transferases (2.1.3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1217Phosphotransferases with a carboxyl group as acceptor (2.7.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • C12N9/92Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013101A 1998-12-22 2001-06-21 Ytre overflateproteiner, deres gener og deres anvendelse NO20013101L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9828346.8A GB9828346D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9901234.6A GB9901234D0 (en) 1999-01-20 1999-01-20 Protein and compositions containing it
GBGB9901233.8A GB9901233D0 (en) 1999-01-20 1999-01-20 Protein and compositions containing it
GBGB9908321.4A GB9908321D0 (en) 1999-04-12 1999-04-12 Purine nucleoside phosphatase and compositions containing it
GBGB9912036.2A GB9912036D0 (en) 1999-05-24 1999-05-24 Glucose-6-phosphate isomerase and compositions containing it
GBGB9922596.3A GB9922596D0 (en) 1999-09-23 1999-09-23 Protein and compositions containing it
PCT/GB1999/004376 WO2000037490A2 (en) 1998-12-22 1999-12-22 Outer surface proteins, their genes, and their use

Publications (2)

Publication Number Publication Date
NO20013101D0 NO20013101D0 (no) 2001-06-21
NO20013101L true NO20013101L (no) 2001-08-13

Family

ID=27547330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013101A NO20013101L (no) 1998-12-22 2001-06-21 Ytre overflateproteiner, deres gener og deres anvendelse

Country Status (24)

Country Link
US (3) US7217415B1 (ru)
EP (2) EP1140994B1 (ru)
JP (1) JP2002533065A (ru)
KR (4) KR100818815B1 (ru)
CN (3) CN1357045A (ru)
AP (1) AP2006003504A0 (ru)
AT (1) ATE297995T1 (ru)
AU (1) AU758722B2 (ru)
BR (1) BR9916473A (ru)
CA (1) CA2354843A1 (ru)
CZ (1) CZ20012174A3 (ru)
DE (1) DE69925866T2 (ru)
DK (1) DK1140994T3 (ru)
EA (1) EA009885B1 (ru)
ES (1) ES2241352T3 (ru)
HK (1) HK1039339A1 (ru)
HU (1) HUP0201022A3 (ru)
NO (1) NO20013101L (ru)
NZ (4) NZ512296A (ru)
OA (1) OA12425A (ru)
PL (1) PL351027A1 (ru)
PT (1) PT1140994E (ru)
SI (1) SI1140994T1 (ru)
WO (1) WO2000037490A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA11734A (en) * 1998-12-22 2005-05-12 Microscience Ltd Genes and proteins, and their use.
US6890539B2 (en) * 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
NZ512296A (en) * 1998-12-22 2003-08-29 Microscience Ltd An outer surface protein MS10 from Group B streptococcus coding for a non-phosphorylating, NADP-dependent glyceraldehyde-3-phosphate dehydrogenase (NPGAP-3-DH)
EP2104512A2 (en) * 2006-12-21 2009-09-30 Emergent Product Development UK Limited Streptococcus proteins, and their use in vaccination
CN103060284A (zh) * 2012-10-31 2013-04-24 内蒙古民族大学 一种无乳链球菌pgk亚单位重组蛋白及其制备方法
CN110669711A (zh) * 2019-08-09 2020-01-10 中国水产科学研究院珠江水产研究所 基于pgk基因的重组乳酸乳球菌和无乳链球菌病疫苗

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678702D1 (de) * 1985-12-28 1991-05-16 Ohgen Research Lab Ltd Antitumorprotein-gen von streptococcus pyogenes su, plasmide, die das gen enthalten, transformantenzellen, die die plasmide beherbergen, und verfahren zur herstellung des antitumorproteins.
US5328996A (en) * 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
WO1993014198A1 (en) * 1992-01-08 1993-07-22 The Rockefeller University Multifunctional surface protein of streptococci
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
NZ263275A (en) 1993-03-19 1997-07-27 Lindahl Gunnar Rib protein from streptococcus, dna encoding it, vectors and compositions
US6346392B1 (en) 1996-11-27 2002-02-12 Smithkline Beecham Corporation Polynucleotides encoding a novel glutamine transport ATP-binding protein
EP1400592A1 (en) * 1996-10-31 2004-03-24 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
US7196164B2 (en) * 1997-07-08 2007-03-27 Human Genome Sciences, Inc. Secreted protein HHTLF25
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7129339B1 (en) * 1997-07-02 2006-10-31 Sanofi Pasteur Limited Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6165763A (en) * 1997-10-30 2000-12-26 Smithkline Beecham Corporation Ornithine carbamoyltransferase
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
NZ512296A (en) * 1998-12-22 2003-08-29 Microscience Ltd An outer surface protein MS10 from Group B streptococcus coding for a non-phosphorylating, NADP-dependent glyceraldehyde-3-phosphate dehydrogenase (NPGAP-3-DH)
US6890539B2 (en) * 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
OA11734A (en) * 1998-12-22 2005-05-12 Microscience Ltd Genes and proteins, and their use.
US6605709B1 (en) * 1999-04-09 2003-08-12 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics

Also Published As

Publication number Publication date
PL351027A1 (en) 2003-02-24
NZ552871A (en) 2008-11-28
WO2000037490A3 (en) 2001-09-20
DE69925866T2 (de) 2005-11-24
AU758722B2 (en) 2003-03-27
HK1039339A1 (en) 2002-04-19
KR20080052527A (ko) 2008-06-11
US20080226641A1 (en) 2008-09-18
KR20060096515A (ko) 2006-09-11
KR20070027665A (ko) 2007-03-09
NO20013101D0 (no) 2001-06-21
EA200100701A1 (ru) 2001-12-24
NZ542777A (en) 2007-11-30
HUP0201022A2 (en) 2002-08-28
AU1877900A (en) 2000-07-12
CN101486756A (zh) 2009-07-22
ES2241352T3 (es) 2005-10-16
KR20010099885A (ko) 2001-11-09
WO2000037490A2 (en) 2000-06-29
DK1140994T3 (da) 2005-08-15
CN1357045A (zh) 2002-07-03
EP1140994A1 (en) 2001-10-10
EP1574579A2 (en) 2005-09-14
EP1140994B1 (en) 2005-06-15
AP2006003504A0 (en) 2006-02-28
KR100818815B1 (ko) 2008-04-01
PT1140994E (pt) 2005-11-30
EP1574579A3 (en) 2006-02-22
NZ512296A (en) 2003-08-29
CN1733800A (zh) 2006-02-15
DE69925866D1 (de) 2005-07-21
CA2354843A1 (en) 2000-06-29
OA12425A (en) 2006-04-18
US7217415B1 (en) 2007-05-15
NZ525538A (en) 2004-10-29
KR100866170B1 (ko) 2008-10-30
BR9916473A (pt) 2002-01-15
SI1140994T1 (sl) 2005-12-31
CZ20012174A3 (cs) 2002-02-13
ATE297995T1 (de) 2005-07-15
EA009885B1 (ru) 2008-04-28
HUP0201022A3 (en) 2004-07-28
US20060104990A1 (en) 2006-05-18
JP2002533065A (ja) 2002-10-08

Similar Documents

Publication Publication Date Title
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
PT851927E (pt) Compostos para imunoterapia e diagnostico de tuberculose
WO1996011279A3 (en) Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
ATE375391T1 (de) Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen
NO20013102D0 (no) Gener, proteiner og deres anvendelse
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
HUP9901035A2 (hu) Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban
DE69732029D1 (de) Dna enthaltende impfstoffen
NO20013101L (no) Ytre overflateproteiner, deres gener og deres anvendelse
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
WO2021158755A3 (en) Leptospiral proteins and uses thereof
WO2004084935A3 (en) Francisella strain for live vaccine
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
Karna et al. Genome sequence of a virulent Pseudomonas aeruginosa strain, 12-4-4 (59), isolated from the blood culture of a burn patient
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
AP1679A (en) Outer surface proteins, their genes, and their use.
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
WO2000077177A3 (en) Isolation of a human retrovirus
CY1108412T1 (el) Συνθεσεις εμβολιου που περιλαμβανουν omp85 πρωτεϊνες απο neisseria gonorrhoea και neisseria miningitidis
DE60040910D1 (de) Inaktivierte zytokine zur immunisierung
WO2000029433A3 (en) 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
CY1111320T1 (el) Cripto ειδικα αντισωματα
MX9709347A (es) Micoplasma synoviae no virulento y vacuna del mismo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application